OBJECTIVES: To present data on the comparative and interactive workplace costs of depression relative to other health problems in the workforce of a large employer. METHODS: The World Health Organization Health and Work Performance Questionnaire was used to assess self-reported health problems and work performance. Survey data were linked to medical-pharmacy claims data. Regression analysis was used to assess comparative effects of depression in the absence and presence of comorbidities on Health and Work Performance Questionnaire measures of work performance. RESULTS: Depression had the largest individual-level effect on work performance of any condition examined. Several comorbid conditions exacerbated the effect of depression, but had no effects in the absence of depression. CONCLUSIONS: Depression is a strong predictor of decrements in work performance. Other conditions that often co-occur with depression, including anxiety and fatigue-sleep disturbance, exacerbate the adverse effect of depression.
OBJECTIVES: To present data on the comparative and interactive workplace costs of depression relative to other health problems in the workforce of a large employer. METHODS: The World Health Organization Health and Work Performance Questionnaire was used to assess self-reported health problems and work performance. Survey data were linked to medical-pharmacy claims data. Regression analysis was used to assess comparative effects of depression in the absence and presence of comorbidities on Health and Work Performance Questionnaire measures of work performance. RESULTS:Depression had the largest individual-level effect on work performance of any condition examined. Several comorbid conditions exacerbated the effect of depression, but had no effects in the absence of depression. CONCLUSIONS:Depression is a strong predictor of decrements in work performance. Other conditions that often co-occur with depression, including anxiety and fatigue-sleep disturbance, exacerbate the adverse effect of depression.
Authors: Frank C Bandiera; Alberto J Caban-Martinez; Kristopher L Arheart; Evelyn P Davila; Lora E Fleming; Noella A Dietz; John E Lewis; David Fabry; David J Lee Journal: Ann Behav Med Date: 2010-05
Authors: Yuki Tomonaga; Josef Haettenschwiler; Martin Hatzinger; Edith Holsboer-Trachsler; Michael Rufer; Urs Hepp; Thomas D Szucs Journal: Pharmacoeconomics Date: 2013-03 Impact factor: 4.981
Authors: Sung-Wei Chen; Po-Chuan Wang; Ping-Lung Hsin; Anthony Oates; I-Wen Sun; Shen-Ing Liu Journal: Int Arch Occup Environ Health Date: 2010-04-30 Impact factor: 3.015
Authors: Maren Nyer; David Mischoulon; Jonathan E Alpert; Daphne J Holt; Charlotte D Brill; Albert Yeung; Paola Pedrelli; Lee Baer; Christina Dording; Ilana Huz; Lauren Fisher; Maurizio Fava; Amy Farabaugh Journal: Ann Clin Psychiatry Date: 2015-05 Impact factor: 1.567
Authors: Frank C Bandiera; Kristopher L Arheart; Alberto J Caban-Martinez; Lora E Fleming; Kathryn McCollister; Noella A Dietz; William G Leblanc; Evelyn P Davila; John E Lewis; Berrin Serdar; David J Lee Journal: Psychosom Med Date: 2009-11-30 Impact factor: 4.312